美国 · 平台与数据 · MarketBeat
PTC Therapeutics (NASDAQ:PTCT) to Buy Back $500 million in Outstanding Stock
PTC Therapeutics (NASDAQ:PTCT - Get Free Report) announced that its Board of Directors has approved a stock buyback program on Tuesday, November 3rd, RTT News reports. The company…
在 MarketBeat 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)





